Detailed instructions and instructions for use of pirfenidone
Pirfenidone is an oral medication used to treat idiopathic pulmonary fibrosis (IPF). IPF is a progressive lung disease that often leads to lung failure. Pirfenidone helps delay the progression of the disease and improve patients' quality of life by slowing down the process of pulmonary fibrosis.
1. Mechanism of action
The mechanism of action of pirfenidone is mainly through inhibiting the production of multiple pro-fibrotic factors, such as transforming growth factorβ (TGF-β) and tumor necrosis factor (TNF). These factors play an important role in the progression of IPF. By blocking the activity of these factors, pirfenidone slows down the fibrotic response and helps repair damaged lung tissue.
2. Indications
Pirfenidone is mainly used to treat idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive lung disease caused by unknown causes. The patient's lungs are gradually replaced by fibrous tissue, eventually causing a decline in lung function. Pirfenidone slows this process, thereby extending patient survival.

3. How to use
The recommended dose of pirfenidone is 200mg three times dailyusually taken after meals. At the beginning of treatment, the dose can be gradually increased, with the maximum dose being 400 mg three times a day. Patients should follow the doctor's instructions during use and regularly check liver function and gastrointestinal reactions.
4. Adverse reactions
Common adverse reactions include nausea, vomiting, loss of appetite, and rash. Some patients may develop abnormal liver function, so liver enzyme levels need to be monitored regularly during treatment. Pirfenidone may also cause photosensitivity reactions, and patients should avoid prolonged exposure to sunlight.
5. Contraindications and Precautions
This medication should be avoided in patients who are allergic to pirfenidone or its components. Additionally, pregnant and breastfeeding women should avoid using this drug. Patients with hepatic insufficiency should use it with special caution and adjust the dose if necessary.
Reference materials:https://www.esbriet.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)